|Bid||0.00 x 1000|
|Ask||0.00 x 800|
|Day's Range||464.57 - 472.51|
|52 Week Range||370.22 - 475.44|
|Beta (5Y Monthly)||0.89|
|PE Ratio (TTM)||16.60|
|Earnings Date||Jul 28, 2021|
|Forward Dividend & Yield||2.80 (0.60%)|
|Ex-Dividend Date||Jun 29, 2021|
|1y Target Est||489.14|
Humana's (HUM) second-quarter earnings results to reflect a steep expense level, partly offset by better revenues.
Humana (HUM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
XSOLIS, the company solving operational challenges in healthcare, is partnering with Humana Inc., a leading health and well-being company, to offer its real-time, predictive analytics platform for utilization review processes between Humana and participating providers. Alongside and in collaboration with participating XSOLIS client health systems, Humana will be adopting Precision Utilization Management (Precision UM), a process by which XSOLIS analytics identify and stratify a subset of member